1993
DOI: 10.1111/j.1365-2125.1993.tb04172.x
|View full text |Cite
|
Sign up to set email alerts
|

The effects of 5‐HT and m‐chlorophenylpiperazine (m‐CPP) on the efflux of [3H]‐5‐HT from human perfused platelets.

Abstract: 1 m-Chlorophenylpiperazine (m-CPP), a S-HTic-receptor agonist, induces migrainelike headaches when taken orally by migraine sufferers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1994
1994
1999
1999

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…20, NO. 3 mCPP Increases Serotonin Release 293 contrast, mCPP does not induce serotonin release from human platelets (Carver et al 1993).…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…20, NO. 3 mCPP Increases Serotonin Release 293 contrast, mCPP does not induce serotonin release from human platelets (Carver et al 1993).…”
Section: Discussionmentioning
confidence: 91%
“…20, NO. 3 mCPP Increases Serotonin Release 293 contrast, mCPP does not induce serotonin release from human platelets (Carver et al 1993).When interpreting the data obtained in clinical studies using mCPP as a pharmacological tool, the possibility that the effects of the drug, at least partly, are caused by the release of endogenous serotonin should be considered. Thus, whereas previous discussions on the mode of action of mCPP have focused on the serotonin receptor subtypes for which the compound displays affinity, the finding that mCPP is an indirect serotonin agonist implies that all serotonin receptors situated in the vicinity of serotonergic nerve terminals, and not concomitantly antagonized by mCPP, may be activated by the drug.…”
mentioning
confidence: 99%
“…MCPP interacts with numerous 5HT receptor, subtype and the 5HT transporter. It acts as an antagonist at the 5HT‐3 receptor, 86,87 as a partial agonist at the 5HT‐1 receptor, 89–90 and as a partial agonist or antagonist at the 5HT‐2 receptor 91–93 . MCPP has relatively low affinity for alpha 1 , alpha 2 , dopamine 1, and dopamine 2 receptors 94,95 .…”
Section: Clinical Neurobiologic Researchmentioning
confidence: 99%